This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Antibody Engineering & Therapeutics Europe

ONLINE REGISTRATION CLOSES IN:

  • 00
    Days
  • 00
    Hrs
  • 00
    Mins
  • 00
    Secs
Delivered as a Hybrid Event, 7 - 9 June, 2022
Live In-Person Event: 7 - 9 June, Postillion Hotel AmsterdamDigital Experience: All Sessions Livestreamed 7 - 9 June

Jonah Rainey, PhD
VP of Antibody Engineering and Protein Science at AlivaMab Discovery Services

Profile

Jonah completed a PhD in Biochemistry at Tufts University and postdoc at University of Wisconsin and the Salk Institute. He has 15 years’ experience in discovery, research and development of bispecific antibodies. He authored several patents and publications describing bispecific platforms and related clinical candidates. He has led many preclinical programs in oncology, infectious disease and autoimmunity. Previous industry experience includes MacroGenics, MedImmune/AZ, Oriole Biotech and Gritstone Oncology.

Agenda Sessions

  • Engineering Human Antibodies Discovered with AlivaMab Mouse into a Dual-Antagonist Bispecific Antibody Therapeutic

    11:50